Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for conservative management of chronic subdural hematoma
NL-OMON29498Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of tranexamic acid in Chronic subdural haematoma (CSDH), sponsored by Amsterdam University Medical Center. Primary endpoints: Need for surgery within 12 weeks and Quality of life at 12 weeks. Planned start Mar 2017; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
Chronic subdural haematoma (CSDH)
Beyond the preview
Go deeper on NL-OMON29498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29498.